ArticleDiagnostics (Basel, Switzerland)2021

Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs.

Enqing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.